SPECT-CT for Assessment of Total Knee Arthroplasty in Navigated and Non-navigated Total Knee Arthroplasty

Overview

By the comparison of two operation methods navigated and non-navigated TKR with SPECT/CT we want to show wich method has the better outcome.

Full Title of Study: “SPECT-CT for Assessment of Patients Before and After Navigated and Conventional Total Knee Arthroplasty.”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: July 2017

Detailed Description

With SPECT/CT we want to controll the clinical outcome of patients who underwent a navigated or a non-navigated TKR.

Interventions

  • Procedure: TKR
    • non-navigated versus computer-navigated total knee replacement

Arms, Groups and Cohorts

  • SPECT/CT before/after navigated TKR
    • SPECT/CT in patients before and after navigated TKR (assessment of bone tracer uptake, 3D CT component position)
  • SPECT/CT before/after conventional TKR
    • SPECT/CT in patients before and after conventional TKR (assessment of bone tracer uptake, 3D CT component position)

Clinical Trial Outcome Measures

Primary Measures

  • which operation method is the best in terms of outcome and SPECT/CT imaging
    • Time Frame: five years

Secondary Measures

  • Improvement in the post-treatment
    • Time Frame: five years

Participating in This Clinical Trial

Inclusion Criteria

  • Total Knee prosthesis (primary)
  • >18 years

Exclusion Criteria

  • pregnancy
  • lactating women
  • endocrine diseases
  • tumour diseases
  • posttraumatic osteoarthritis of the knee
  • previous infection of the knee
  • medicaments which influence the metabolism of the bone

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Kantonsspital Baselland Bruderholz
  • Provider of Information About this Clinical Study
    • Principal Investigator: Michael Tobias Hirschmann, PD Dr. med. – Kantonsspital Baselland Bruderholz
  • Overall Official(s)
    • MIchael T. Hirschmann, MD, Principal Investigator, Dept. of Orthop. Surgery and Traumatology, Kantonsspital Baselland – Bruderholz, Unitverstity of Basel, Switzerland

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.